PTC Therapeutics
PTCT
#2794
Rank
S$7.70 B
Marketcap
S$96.00
Share price
-1.18%
Change (1 day)
40.30%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: S$7.70 Billion

As of February 2026 PTC Therapeutics has a market cap of S$7.70 Billion. This makes PTC Therapeutics the world's 2794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$7.70 B-4.82%
2025S$8.09 B70.79%
2024S$4.74 B72.63%
2023S$2.74 B-26.45%
2022S$3.73 B-1.91%
2021S$3.80 B-30.9%
2020S$5.50 B37.37%
2019S$4.01 B69.03%
2018S$2.37 B156.34%
2017S$0.92 B70.81%
2016S$0.54 B-65.14%
2015S$1.55 B-30.93%
2014S$2.25 B339.72%
2013S$0.51 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of PTC Therapeutics was reported to be:

S$7.70 Billion
by Nasdaq info icon info icon
S$7.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
S$362.60 B 4,604.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
S$153.12 B 1,886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$1.09 B-85.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.70 B-64.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.17 B-97.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
S$13.89 B 80.31%๐Ÿ‡บ๐Ÿ‡ธ USA